56 days
Median Publication Time

Medical Sciences Forum, Volume 48, 2026

IECC 2026 - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Proceeding Paper

113 Views

24 Pages

Network Pharmacology-Based Elucidation of Piperlongumine Action on Oncogenic Survival and Immune-Evasive Pathways in Pancreatic Cancer

Imene Derardja,
Redouane Rebai,
Luc Jasmin and
Abdennacer Boudah

Med. Sci. Forum2026, 48(1), 3;https://doi.org/10.3390/msf2026048003

28 August 2026

Pancreatic cancer (PC) remains one of the most aggressive malignancies, largely due to late diagnosis, rapid metastatic progression, and the limited efficacy of current therapeutics. Piperlongumine, a bioactive alkaloid isolated from Piper longum, ha...

Full Article

Proceeding Paper

327 Views

9 Pages

NDS: A Novel Deep Learning-Based Systems Biology Framework for Identifying Prognostic Biomarkers in Hepatocellular Carcinoma

Muhammad Zurgham Akram and
Mehwish Majeed

Med. Sci. Forum2026, 48(1), 2;https://doi.org/10.3390/msf2026048002

31 July 2026

Hepatocellular carcinoma (HCC) is an aggressive liver cancer requiring reliable biomarkers, while current approaches are limited by high-dimensional data and complex nonlinear gene interactions. In this study, differentially expressed genes were iden...

Full Article

Proceeding Paper

326 Views

9 Pages

In Silico Gene Expression Profiling Maps the Drivers of Pan-Cancer Progression

Mehwish Majeed and
Muhammad Zurgham Akram

Med. Sci. Forum2026, 48(1), 1;https://doi.org/10.3390/msf2026048001

29 July 2026

Clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC), lung adenocarcinoma (LUAD), and pancreatic ductal adenocarcinoma (PDAC) are highly lethal cancers that share molecular mechanisms underlying tumor progression, yet common biomar...

Full Article

Med. Sci. Forum - ISSN 2673-9992

Imprint

Download Flyer